Zobrazeno 21 - 30
of 84
pro vyhledávání: '"329"'
Autor:
Evandro D. Bezerra, Brenda M. Sandmaier, Linde M. Morsink, Megan Othus, H. Joachim Deeg, H. Gary Schoch, Brent L. Wood, Min Fang, Frederick R. Appelbaum, Roland B. Walter
Publikováno v:
Blood. 134:321-321
Background:Myeloablative allogeneic hematopoietic cell transplantation (HCT) is a common post-remission treatment strategy for medically fit adults with acute myeloid leukemia (AML) in morphologic remission. Several conditioning regimens have been ut
Autor:
Neel Raja, Oliver C Cohen, Aoife Dervin, Max Brodermann, S Morley, Kirit M. Ardeshna, Ian Proctor, William Townsend
Publikováno v:
Blood. 134:4746-4746
Introduction Lymph node excision has historically been preferred to core biopsy in diagnosing lymphoma given reported higher diagnostic yield and concerns that core biopsies yielded insufficient material. However, core biopsy is associated with lower
Autor:
Tony Reiman, Donna E. Reece, Eshetu G. Atenafu, Martha L Louzada, Christopher P. Venner, Muhammad Aslam, Michael Sebag, Kevin W. Song, Arleigh McCurdy, Richard Leblanc, Esther Masih-Khan, Julie Stakiw, Darrell White, Engin Gul, Rami Kotb, Victor H Jimenez-Zepeda
Publikováno v:
Blood. 134:1886-1886
Lenalidomide in combination with dex (Len + dex) was introduced as treatment for relapsed/refractory myeloma in Canada over a decade ago; more recently, Len has been routinely available as part of first-line therapy, both in transplant-eligible patie
Publikováno v:
Blood. 132:4979-4979
Background Although significant advances have been made over the past 10 years in the treatment of Immune Thrombocytopenia (ITP), challenges remain in addressing the burden of disease and unmet needs of patients. In rare diseases especially, natural
Autor:
Suzanne R. Hayman, Morie A. Gertz, Steven R. Zeldenrust, Francis K. Buadi, Miriam Hobbs, Moritz Binder, Shaji Kumar, Martha Q. Lacy, Angela Dispenzieri, Wilson I. Gonsalves, Ronald S. Go, Prashant Kapoor, John A. Lust, Robert A. Kyle, Taxiarchis Kourelis, S. Vincent Rajkumar, Rahma Warsame, Amie Fonder, Stephen J. Russell, Nelson Leung, Arjun Lakshman, Lisa Hwa
Publikováno v:
Blood. 132:4497-4497
Background: The introduction of novel therapeutics has led to improved outcomes in patients with multiple myeloma (MM). MM and its precursor lesion smoldering multiple myeloma (SMM) have traditionally been associated with increased mortality despite
Autor:
Myriam Rodríguez, Abel Berrios, Denisse Castro, Maria Elena Cabrera, Camila Peña, Carlos S. Chiattone, Victoria Otero, Fabiola Valvert Gamboa, Raul Gabus, Marialejandra Torres Viera, Teodoro Chisesi, Gregorio Ignacio, Brady E Beltran, Eduardo M. Sotomayor, Gabriel Borelli, Jorge J. Castillo, Sally Rose Paredes
Publikováno v:
Blood. 132:5395-5395
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of lymphoma in the world and corresponds to a heterogeneous entity, both from the clinical and molecular point of view, being its prognosis of survival very variable The
Publikováno v:
Blood. 132:2515-2515
Introduction: The introduction of direct oral anticoagulants (DOAC) has revolutionised the treatment of atrial fibrillation (AF) and venous thromboembolism (VTE). Previous clinical trials have demonstrated that DOACs are non-inferior to warfarin for
Autor:
Yuan-Shung Huang, Brian T. Fisher, Richard Aplenc, Karen R. Rabin, Kelly D. Getz, Jennifer J. Wilkes, Viviane C. Cahen, Yimei Li, Lena E. Winestone, Amanda M. DiNofia, M. Monica Gramatges, Alix E. Seif, Caitlin W Elgarten
Publikováno v:
Blood. 132:624-624
Administrative databases can be used to study outcomes including patients outside of clinical trials and have been used to identify relapse and HSCT in adult and adolescent/young adult leukemia populations. However, there are no published studies usi
Autor:
Shyamali Dutta, Prantar Chakrabarti, Prakas Kumar Mandal, Shuvra Neel Baul, Tuphan Kanti Dolai, Rajib De, Ankita Sen
Publikováno v:
Blood. 132:2348-2348
Introduction: β Haemoglobinopathy, is one of the commonest inherited disorders, with a higher prevalence in the eastern part of India. In view of the lack of facilities for allogeneic stem cell transplantation, including financial constraints, this
Autor:
Binal N. Shah, Rasha Raslan, Jin Han, Michel Gowhari, Andrew Srisuwananukorn, Xu Zhang, Robert E. Molokie, Santosh L. Saraf, Victor R. Gordeuk
Publikováno v:
Blood Adv
Sickle cell disease (SCD) is an inherited red blood cell disorder that leads to vaso-occlusion, endothelial damage, and activation of pro-coagulant pathways. Recent studies have demonstrated that thrombotic episodes occur at a 3- to 100-fold higher r